FDA NDC Directory · JSON-LD · Markdown
NDC 65649-311 · HUMAN PRESCRIPTION DRUG · SUSPENSION
| Generic name | CHLOROTHIAZIDE |
|---|---|
| Labeler / Manufacturer | Salix Pharmaceuticals, Inc |
| Marketing category | New Drug Application (innovator) · App NDA011870 |
| Dosage form / route | SUSPENSION · ORAL |
| Active ingredients | CHLOROTHIAZIDE (250 mg/5mL) |
| Marketing started | 19620215 |
| Marketing ended | 20280131 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).